Avalon GloboCare Corp.
(NASDAQ: ALBT)
Avalon GloboCare Corp. is a clinical-stage biotechnology company, which engages in the development of immune effector cell therapy and laboratory services. It operates through the Real Property Operating and Medical Related Consulting Services segments. The Real Property Operating segment includes property management fees, property insurance, real estate taxes, depreciation, repairs and maintenance fees, utilities and other expenses related to rental properties. The Medical Related Consulting segment relates to labor and related benefits, travel expenses, and related to consulting services. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.
1.500
+0.040
(+2.74%)
Range
1.440 - 1.521
(5.62%)
Open
1.470
Previous Close
1.460
Bid Price
1.800
Bid Volume
9
Ask Price
2.100
Ask Volume
13
Volume
13,904
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis